Abstract

Compounding Metformin for Use in Functional Medicine

Author(s): Desai Sarina, Thompson Tara

Issue: Sep/Oct 2023 - Volume 27, Number 5

Page(s): 362-366

Download in electronic PDF format for $75
  • Compounding Metformin for Use in Functional Medicine Page 1
  • Compounding Metformin for Use in Functional Medicine Page 2
  • Compounding Metformin for Use in Functional Medicine Page 3
  • Compounding Metformin for Use in Functional Medicine Page 4
  • Compounding Metformin for Use in Functional Medicine Page 5

Abstract

The most common reason for metformin incompliance is due to its side-effect profile. Metformin can cause issues with the gastrointestinal tract and result in nausea, abdominal pain, diarrhea, bloating, or vomiting. The size of the metformin tablet, which is quite large, is another reason for incompliance. Compounding pharmacists can prepare a topical formulation of metformin, which helps eliminate the unwanted gastrointestinal side effects, as well as eliminate the incompliance due to the size of the tablet. The transdermal use of metformin also allows the patient to take a much lower dosage compared to oral metformin. An oral liquid formulation can also help resolve the issue of swallowing a large tablet for those patients who are diagnosed with dysphagia.

Related Keywords

  • metformin
  • biguanides
  • adverse effects
  • noncompliance
  • gastrointestinal symptoms
  • large tablet size
  • transdermal administration
  • topical preparation
  • oral liquid formulation
  • diabetes mellitus
  • hyperglycemia
  • type 2 diabetes
  • high blood sugar
  • insulin
  • diabetes complications
  • microvascular complications
  • macrovascular complications
  • antihyperglycemic agents
  • glucose resistance
  • off-label uses
  • formulations

Related Categories

  • DIABETES
  • FORMULATIONS
  • ADVERSE DRUG EVENTS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2023
Pg. 362-366
Compounding Metformin for Use in Functional Medicine
Author(s): Desai Sarina, Thompson Tara
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2019
Pg. 65-69
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2007
Pg. 157
Metformin Hydrochloride 100-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 17-20
Diabetes Mellitus: Pathophysiology and Complications
Author(s): Meece Jerry
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
Nov/Dec 2018
Pg. 446-454
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Author(s): Zur Eyal
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Sep/Oct 2023
Pg. 424-430
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Mar/Apr 2012
Pg. 110-114
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Author(s): Griffee Chris, Delano Amy